Herriot Tabuteau Axsome Therapeutics, Inc. (AXSM) insider trading activity

Herriot Tabuteau is Chief Executive Officer of Axsome Therapeutics, Inc.. Currently has a direct ownership of 7,229 shares of AXSM, which is worth approximately $844,202. The most recent transaction as insider was on Sep 16, 2025, when has been sold 19,719 shares (Common Stock) at a price of $114.19 per share, resulting in proceeds of $2,251,712. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.23K

n/a 3M change

n/a 12M change

Total Value Held $844,202

HERRIOT TABUTEAU Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2025	SELL Open market or private sale	$2,251,712 $114.19 p/Share	19,719 Reduced 73.17%	7,229 Common Stock
Sep 16 2025	BUY Exercise of conversion of derivative security	$158,146 $8.02 p/Share	19,719 Added 42.25%	26,948 Common Stock
Sep 15 2025	SELL Open market or private sale	$1,790,361 $117.37 p/Share	15,254 Reduced 67.85%	7,229 Common Stock
Sep 15 2025	BUY Exercise of conversion of derivative security	$122,337 $8.02 p/Share	15,254 Added 40.42%	22,483 Common Stock
Sep 12 2025	SELL Open market or private sale	$3,319,816 $118.96 p/Share	27,907 Reduced 79.43%	7,229 Common Stock
Sep 12 2025	BUY Exercise of conversion of derivative security	$223,814 $8.02 p/Share	27,907 Added 44.27%	35,136 Common Stock

Herriot Tabuteau

Chief Executive Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Value

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM

Account